Show simple item record

The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon

dc.contributor.authorOberle, Rebecca L.en_US
dc.contributor.authorAmidon, Gordon L.en_US
dc.date.accessioned2006-09-11T15:35:52Z
dc.date.available2006-09-11T15:35:52Z
dc.date.issued1987-10en_US
dc.identifier.citationOberle, Rebecca L.; Amidon, Gordon L.; (1987). "The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon." Journal of Pharmacokinetics and Biopharmaceutics 15(5): 529-544. <http://hdl.handle.net/2027.42/45037>en_US
dc.identifier.issn1573-8744en_US
dc.identifier.issn0090-466Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/45037
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3694496&dopt=citationen_US
dc.description.abstractA physiological flow model is presented to account for plasma level double peaks based on cyclical gastric emptying and intestinal motility in the fasted state. Central to the model is the assumption that gastric emptying and intestinal transit rates will vary directly with the strength of the contractile activity characteristic of the fasted state motility cycle. Simulated curves clearly indicate that variable gastric emptying rates can result in variable absorption rates from the gastrointestinal tract and double peaks in the plasma level curves of cimetidine. Vital to the occurrence of double peaks are (i) dosing time relative to phasic activity, (ii) variability in flow out of the stomach, and (iii) a small emptying rate constant Q s /V s , for a period of time within the first hour after administration. Variability in intestinal flow rates alone does not cause a double peak in the plasma level curve. Results of the simulations, as well as experimental results, can be categorized according to the shapes of the plasma level curves into four types: type A, C pmax (1) <C pmax (2); type B, single peak; type C, C pmax (1)>C pmax (2); type D, C pmax (1)=C pmax (2). Assuming that the experimental results were obtained from fasted subjects, with the time of dose administration being a random variable, the frequency of the experimental curves having shape A, B, C, or D correlates extremely well with theoretical predictions. It is concluded that variable gastric emptying rates due to the motility cycle can account for plasma level double peaks. Furthermore, variable gastric emptying rates combined with the short plasma elimination half-life and poor gastric absorption of cimetidine can be the cause of the frequently observed plasma level double peaks.en_US
dc.format.extent875860 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Mediaen_US
dc.subject.otherVeterinary Medicineen_US
dc.subject.otherBiomedical Engineeringen_US
dc.subject.otherGastric Emptyingen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherPharmacyen_US
dc.subject.otherBiochemistry, Generalen_US
dc.subject.otherCimetidineen_US
dc.subject.otherOral Absorptionen_US
dc.subject.otherDouble Peaksen_US
dc.subject.otherFasted Motilityen_US
dc.titleThe influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenonen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, 48109-1065, Ann Arbor, Michiganen_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, 48109-1065, Ann Arbor, Michiganen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid3694496en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/45037/1/10928_2005_Article_BF01061761.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF01061761en_US
dc.identifier.sourceJournal of Pharmacokinetics and Biopharmaceuticsen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.